IO Biotech, Inc. (IOBTQ) Change in Accured Expenses (2020 - 2025)

IO Biotech (IOBTQ) has 6 years of Change in Accured Expenses data on file, last reported at -$1.7 million in Q3 2025.

• Quarterly Change in Accured Expenses fell 180.49% year-over-year to -$1.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.2 million (down 50.38% YoY) and the FY2024 annual result came in at $2.9 million, down 41.85% from the prior year.
• Change in Accured Expenses fell to -$1.7 million in Q3 2025, from $1.2 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.5 million in Q4 2023 to a low of -$4.6 million in Q1 2024.
• A 5-year average of $514842.1 and a median of -$85000.0 in 2023 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 2542.35% in 2024, down 650.73% in 2024.
• Tracing IOBTQ's Change in Accured Expenses over 5 years: stood at $3.1 million in 2021, then dropped by 14.99% to $2.7 million in 2022, then soared by 104.87% to $5.5 million in 2023, then slipped by 26.85% to $4.0 million in 2024, then sank by 141.74% to -$1.7 million in 2025.
• The last three Change in Accured Expenses figures came in at -$1.7 million (Q3 2025), $1.2 million (Q2 2025), and -$1.4 million (Q1 2025), per Business Quant data.